It is my pleasure to inform the readership that the impact factor of JBME went up from 1.6 in 2010 to 1.9 in 2011. Submissions continue to substantially increase, with the 2011 total submissions at 552, up from 459 in 2010, and with a projected total of 630 at the current submission rate for 2012. Moreover, the net review time is now down to only one month from submission to the first Associate Editor Recommendation. JBME remains the most selective ASME journal, with an acceptance rate of 27%. This is a great sign that our collective efforts to raise impact factors and lower review times are working. Special thanks to the Reviewers and Associate Editors who do most of the real work of the Journal, as well as to the Bioengineering Division Chairs and the Executive Council for their hard work and support over the last five years.

Next, there are some exciting new developments for the Journal. Last fall, I put forward a proposal to convert JBME to a dual editor system. This was done to not only help with the increased workload but also to assist the Journal to undertake new initiatives, such as the new focus on special issues. I am very pleased to announce that the Bioengineering Division Executive Council has chosen Dr. Beth Winkelstein of the University of Pennsylvania and Dr. Victor Barocas of the University of Minnesota as the new Co-Editors of JBME. Dr. Winkelstein started her term on Jan. 1, 2012, and Dr. Barocas will start his term in early Fall 2012. Once both editors are on board, Dr. Winkelstein will be handling all musculoskeletal related manuscripts, while Dr. Barocas will be handling cardiovascular and soft tissue related areas. I am also very pleased to announce Dr. Winkelstein as the first woman editor of JBME.

As I come to the end of my five year term as Editor, I would like to extend my thanks to all authors for helping to make JBME an outstanding journal, and to above all to encourage you to submit your best work to the Journal.